NAYA Biosciences, Inc (NAYA) — Strategic Asset Allocation Index
NAYA Biosciences, Inc (NAYA) has a Strategic Asset Allocation Index of 5.8% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $740.76K) total $740.76K, measured against net assets of $12.75 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
NAYA Biosciences, Inc Strategic Asset Allocation Index (2020–2024)
This chart shows how NAYA Biosciences, Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2020 to 2024. As of December 2024, the index stands at 5.8%, representing strategic assets of $740.76K against net assets of $12.75 Million USD. See NAYA Biosciences, Inc (NAYA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for NAYA Biosciences, Inc (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for NAYA Biosciences, Inc from 2020 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NAYA market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 5.8% | $740.76K | $- | $740.76K | $12.75 Million | ▼ -340.2 pp |
| 2023 | 346.0% | $3.09 Million | $- | $3.09 Million | $892.60K | ▲ +325.6 pp |
| 2021 | 20.4% | $1.49 Million | $- | $1.49 Million | $7.31 Million | ▲ +18.7 pp |
| 2020 | 1.7% | $98.08K | $- | $98.08K | $5.74 Million | — |